Clinical Trial Update: The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating results on low-dose human growth hormone therapy in HIV-infected patients, including those with lipodystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Lipodystrophy

Drugs mentioned

• Human Growth Hormone (somatropin)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: HIV Infections, Lipodystrophy | Phase 4 | Status: COMPLETED